Ce succès témoigne de la solidité et de la compétitivité de la communauté de recherche de la Faculté de médecine à l’échelle nationale et souligne sa contribution soutenue à l’amélioration des résultats en santé, au Canada comme à l’international.
Subventions Projet des IRSC – automne 2025 :
Jean-Claude Béïque (MCM) : “Role of ATRX in hippocampal function”
Mireille Khacho (BMI) : “Redox signaling via protein S-glutathionylation in muscle stem cell function and muscle repair”
Monique Potvin Kent (ÉÉSP) : “Digital Diets: The Impact of Restaurant and Food Delivery Service Apps on Young Canadians”
Paul Albert (Médecine/IRHO): “Targeting neuroplasticity to overcome treatment-resistant depression”
Antonio Colavita (MCM/IRHO) : “Establishing C. elegans Ventral Nerve Cord Formation as a Model for Cell Positioning and Sorting”
Daniel McIsaac (Anesthésiologie et médecine de la douleur/IRHO) : “STRIVE before surgery trial: a pragmatic multicenter randomized trial of Structured TRaining to Improve fitness in a Virtual Environment before surgery”
Lynn Megeney (Médecine/IRHO) : “Small molecule induction of physiologic hypertrophy to limit/reverse heart failure”
David Picketts (Médecine/IRHO) : “Defining the requirement of the ATRX chromatin remodeling protein for the specification and development of the entorhinal cortex-hippocampal circuitry”
Justin Presseau (ÉÉSP/IRHO) : “Building and sustaining trust in healthcare: Co-developing a compendium of equitable strategies for building, rebuilding and maintaining trust”
Michael Rudnicki (Médecine/IRHO) : “Muscle stem cell dysfunction in cancer cachexia”
William Stanford (MCM/IRHO) : “Cellular and molecular pathogenesis of renal tuberous sclerosis complex”
Bernard Thébaud (Pédiatrie/IRHO/IR CHEO) : “Lung specific AAV gene therapy for inherited disorders of surfactant metabolism”
Jodi Warman Chardon (Médecine/IRHO) : “OPMDx- Canadian Oculopharyngeal Muscular Dystrophy Biomarkers Study”
Munir Boodhwani (Chirurgie/ICUOI) : “Comparing hypOtherMic teMperaturEs duriNg hemiarCh surgEry: COMMENCE Trial”
Wenbin Liang (MCM/ICUO) : “Role of Wnt5a in Arrhythmogenesis of Heart with Ischemic Cardiomyopathy”
Hassan Mir (Médecine/ICUO) : “Varenicline, Cytisine, or Placebo for Vaping Cessation in Adult Exclusive E-Cigarette Users: A Triple-Blinded, Multi-Centre Randomized Controlled Trial (VICTORY RCT)”
Daniel Ramirez (Médecine/ICUO) : “Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical storm (SEDATE)”
Zakia Djaoud (BMI/IR CHEO) : “Exploring the education of gd T cells to foster their therapeutic potential”
Vivian Welch (ÉÉSP/IRSB) : “Evidence and Gap Maps for health equity: A strategic tool to drive transformative health research priorities”
Annonces de priorités des IRSC – automne 2025 :
Bernard Jasmin (MCM) : “Characterizing the implication and therapeutic potential of AMPK signaling in Myotonic Dystrophy Type 1 (DM1)”
Elizabeth Potter (ÉÉSP) : “Developing and implementing a core outcome set for adolescents and adults with phenylketonuria”
Dean Fergusson (Médecine/IRHO) : “LabPartners-Nexus: Embedding patient engagement in preclinical research across Canada's Strategy for Patient-Oriented Research (SPOR) Support units.”
Derek MacFadden (Médecine/IRHO) : “Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial”
Daniel McIsaac (Anesthésiologie et médecine de la douleur/IRHO) : “The Canadian Prehabilitation Network Review: a living systematic review to support advanced knowledge synthesis informing prehabilitation design and evaluation”
James Downar (Médecine/IRSB) : “PSilocybin microdose for psYCHological and Existential Distress in PALliative care (PSYCHED-PAL): An open-label extension of a multi-site phase 3 double-blind, placebo-controlled, parallel-arm clinical trial”
Jennifer Reed (ÉÉSP/ICUO) : “Exercise Training in Patients with Atrial Fibrillation: A Randomized Controlled Trial”